|
|
| | Timolumab Basic information |
| Product Name: | Timolumab | | Synonyms: | Timolumab;Research Grade Timolumab (DHH39201);Research Grade Timolumab;Timolumab (anti-AOC3) | | CAS: | 1073538-99-4 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Timolumab Structure]() |
| | Timolumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Timolumab Usage And Synthesis |
| Uses | Timolumab (BTT1023 ), a recombinant fully human monoclonal antibody that specifically binds VAP-1. Timolumab (BTT1023 ) could be used in the study of chronic inflammatory diseases[1][2]. | | References | [1] Ahmad H Ali, et al. Novel treatments in primary sclerosing cholangitis. Clin Liver Dis (Hoboken). 2016 Nov 30;8(5):132-135. DOI:10.1002/cld.588
[2] Takayuki Inoue, et al. Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema. Bioorg Med Chem. 2013 Mar 1;21(5):1219-33. DOI:10.1016/j.bmc.2012.12.025
[3] Anu Autio, et al. Preclinical evaluation of a radioiodinated fully human antibody for in vivo imaging of vascular adhesion protein-1-positive vasculature in inflammation. J Nucl Med. 2013 Aug;54(8):1315-9. DOI:10.2967/jnumed.113.120295 |
| | Timolumab Preparation Products And Raw materials |
|